Merck Group’s Frank Schoeneborn on patent boxes, people functions and profit splits
Frank Schoeneborn, head of operational transfer pricing at Merck Group, shares his views on BEPS progress, issues of confidentiality and the increasingly negative press transfer pricing is receiving.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: